| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8778366 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) | |
| US9968553 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) | |
| US8568747 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) | |
| US9855214 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) | |
Epaned Kit is owned by Silvergate Pharms.
Epaned Kit contains Enalapril Maleate.
Epaned Kit has a total of 4 drug patents out of which 0 drug patents have expired.
Epaned Kit was authorised for market use on 13 August, 2013.
Epaned Kit is available in for solution;oral dosage forms.
Epaned Kit can be used as treatment of hypertension; method of treatment of heart failure; method of treating hypertension; treatment of heart failure; method of treating left ventricular dysfunction, method of treatment of heart failure; treatment of hypertension; method of treating left ventricular dysfunction; method of treating hypertension; treatment of heart failure.
The generics of Epaned Kit are possible to be released after 06 November, 2032.
Drugs and Companies using ENALAPRIL MALEATE ingredient
Market Authorisation Date: 13 August, 2013
Treatment: Treatment of hypertension; Method of treatment of heart failure; Method of treating hypertension; Treatment of heart failure; Method of treating left ventricular dysfunction
Dosage: FOR SOLUTION;ORAL
EPANED KIT family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic